AMORCYTE MYOCARDIAL REPAIR STUDY- A Phase I Trial of Intra-Coronary Infusion of Bone Marrow Derived Autologous CD34+ Selected Cells in Patients With Acute Myocardial Infarction. (AMRS).
Phase of Trial: Phase I
Latest Information Update: 15 Nov 2013
At a glance
- Drugs NBS 10 (Primary)
- Indications Myocardial infarction
- Focus Adverse reactions
- Acronyms AMRS
- 10 Jun 2017 Biomarkers information updated
- 02 Feb 2010 Planned end date (Mar 2012) added as reported by ClinicalTrials.gov.
- 30 Mar 2009 Results presented at the American College of Cardiology Annual Scientific Session, as reported by Amorcyte.